Task: Answer the multiple choice question.
Question: Which drug exhibits a 11.703\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) Cc1ccc(CN2C(=O)S/C(=C\c3ccccc3OCC(=O)O)C2=O)cc1
b.) Clc1ccc(Sc2cnc3ccccc3n2)cc1
c.) CCN1C(=O)/C(=C\N2CCN(C(=O)c3ccco3)CC2)SC1=S
Answer: c. CCN1C(=O)/C(=C\N2CCN(C(=O)c3ccco3)CC2)SC1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1C(=O)/C(=C\N2CCN(C(=O)c3ccco3)CC2)SC1=S
CCN1C(=O)/C(=C\N2CCN(C(=O)c3ccco3)CC2)SC1=S
(5E)-3-ethyl-5-[[4-(furan-2-carbonyl)piperazin-1-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one